2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
6
Recruiting
6
Completed
4
Terminated
2
Withdrawn
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
1
Adenocarcinoma
1
Interventions
Carboplatin
127
Cisplatin
125
Drug Therapy
117
Bevacizumab
102
Oxaliplatin
99
Capecitabine
99
Radiotherapy
97
Gemcitabine
87
tislelizumab
86
Paclitaxel
86
Cyclophosphamide
86
Specimen Handling
80
pembrolizumab
76
toripalimab
68
Magnetic Resonance Spectroscopy
65
Fluorouracil
63
Injections
62
sintilimab
58
Surgical Procedures, Operative
58
anlotinib
53
Docetaxel
52
130-nm albumin-bound paclitaxel
50
fludarabine
47
Standard of Care
46
Pemetrexed
45
Immune Checkpoint Inhibitors
45
Blood Specimen Collection
43
Biopsy
43
venetoclax
42
Leucovorin
42
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Poly(ADP-ribose) Polymerase Inhibitors
×
Clear all
NCT07268794
2025-12-08
CONVERT-HB1
Fudan University
Phase 2
Not yet recruiting
112 enrolled